2024
DOI: 10.1016/j.jbc.2023.105593
|View full text |Cite
|
Sign up to set email alerts
|

Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation

Zhiyi Liu,
Qinghe Hu,
Bin Hu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Zhaowei Qu et al conducted a comprehensive bioinformatics study on the potential molecular mechanisms of TGF-β activation in HCC cells, and found that TGF-β may affect the biological processes of HCC cells via regulatory pathways such as SMAD2/SMAD3-NEDD4 and HNF4A-CUL4 B/NEDD4, which provides a new direction for further research on HCC [140]. Zhiyi Liu et al reported that NEDD4 could regulate the ERK signaling pathway by inducing the ubiquitination degradation of protocadherin 17 (PCDH17), which would then promote the proliferation of HCC cells [101]. Surprisingly, another study revealed that the expression of NEDD4L was downregulated in HCC tissues compared with paraneoplastic tissues, and by analyzing the relationship between NEDD4L and the clinicopathological features of HCC patients, NEDD4L was shown to exert a tumor suppressor effect in HCC by triggering MAPK/ERK-mediated apoptosis.…”
Section: Nedd4/neddl and Liver Diseases 221 Nedd4/neddl And Liver Cancermentioning
confidence: 99%
“…Zhaowei Qu et al conducted a comprehensive bioinformatics study on the potential molecular mechanisms of TGF-β activation in HCC cells, and found that TGF-β may affect the biological processes of HCC cells via regulatory pathways such as SMAD2/SMAD3-NEDD4 and HNF4A-CUL4 B/NEDD4, which provides a new direction for further research on HCC [140]. Zhiyi Liu et al reported that NEDD4 could regulate the ERK signaling pathway by inducing the ubiquitination degradation of protocadherin 17 (PCDH17), which would then promote the proliferation of HCC cells [101]. Surprisingly, another study revealed that the expression of NEDD4L was downregulated in HCC tissues compared with paraneoplastic tissues, and by analyzing the relationship between NEDD4L and the clinicopathological features of HCC patients, NEDD4L was shown to exert a tumor suppressor effect in HCC by triggering MAPK/ERK-mediated apoptosis.…”
Section: Nedd4/neddl and Liver Diseases 221 Nedd4/neddl And Liver Cancermentioning
confidence: 99%